Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure

Karen Rowland Yeo, Jane R. Kenny, Amin Rostami-Hodjegan

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science